Loading...
Baxter International Inc.
BAX•NYSE
HealthcareMedical - Instruments & Supplies
$30.25
$0.10(0.33%)
Baxter International Inc. (BAX) Financial Performance & Statements
Review Baxter International Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-28.20%
↓ 28.20%
Operating Income Growth
-128.72%
↓ 128.72%
Net Income Growth
-124.44%
↓ 124.44%
Operating Cash Flow Growth
-40.96%
↓ 40.96%
Operating Margin
-3.48%
↓ 3.48%
Gross Margin
36.03%
↑ 36.03%
Net Profit Margin
-4.71%
↓ 4.71%
ROE
-7.58%
↓ 7.58%
ROIC
-2.32%
↓ 2.32%
Baxter International Inc. (BAX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Baxter International Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.75B | $2.70B | $3.81B | $3.59B |
| Cost of Revenue | $1.79B | $1.67B | $2.38B | $2.24B |
| Gross Profit | $959.00M | $1.03B | $1.43B | $1.35B |
| Gross Profit Ratio | $0.35 | $0.38 | $0.38 | $0.38 |
| R&D Expenses | $211.00M | $129.00M | $173.00M | $160.00M |
| SG&A Expenses | $761.00M | $754.00M | $1.02B | $857.00M |
| Operating Expenses | $1.39B | $878.00M | $1.19B | $1.02B |
| Total Costs & Expenses | $3.19B | $2.54B | $4.004B | $3.26B |
| Interest Income | $10.00M | $0.00 | $19.00M | $25.00M |
| Interest Expense | $100.00M | $87.00M | $104.00M | $103.00M |
| Depreciation & Amortization | $245.00M | $129.00M | $288.00M | $335.00M |
| EBITDA | -$176.00M | $299.00M | $133.00M | $696.00M |
| EBITDA Ratio | -$0.06 | $0.11 | $0.03 | $0.19 |
| Operating Income | -$435.00M | $155.00M | -$192.00M | $332.00M |
| Operating Income Ratio | -$0.16 | $0.06 | -$0.05 | $0.09 |
| Other Income/Expenses (Net) | -$86.00M | -$86.00M | -$65.00M | -$71.00M |
| Income Before Tax | -$521.00M | $69.00M | -$257.00M | $116.00M |
| Income Before Tax Ratio | -$0.19 | $0.03 | -$0.07 | $0.03 |
| Income Tax Expense | -$33.00M | $8.00M | $54.00M | $77.00M |
| Net Income | -$512.00M | $140.00M | -$314.00M | $37.00M |
| Net Income Ratio | -$0.19 | $0.05 | -$0.08 | $0.01 |
| EPS | -$1.00 | $0.27 | -$0.62 | $0.07 |
| Diluted EPS | -$1.00 | $0.27 | -$0.62 | $0.07 |
| Weighted Avg Shares Outstanding | $510.00M | $510.00M | $510.00M | $508.00M |
| Weighted Avg Shares Outstanding (Diluted) | $510.00M | $512.00M | $510.00M | $510.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan